Oral Board Review Course (2024)

February 10, 2024 to February 11, 2024

Please note that the Oral Board Review Course is SOLD OUT. If you would like to be added to the waitlist, call 1-800-908-9414 or email registration@AUAnet.org.

 

Saturday Session- SOLD OUT!

Sunday Session- SOLD OUT!

The 2024 AUA Oral Board Review Course will take place as a live virtual course.

The purpose of the AUA Oral Board Review Course is to prepare attendees for the American Board of Urology (ABU) Certifying Examination (Part II). The course will provide attendees with valuable practice and practical preparation skills for taking the urology oral board exam. This is a highly interactive course that emulates the oral board exam given by the American Board of Urology. Attendees participate in two-75 minute mock oral exams, an Objective Structured Clinical Examination (OSCE) role play practice session, an interactive case analysis with expert examiners, take home cases and an “Ask the Experts” panel discussion with Faculty who offer tips & tricks for preparing for and successfully taking the oral examination.

In addition to experiencing mock oral exams that are realistic, attendees will also receive immediate feedback and guidance from expert oral examiners, as well as the opportunity to refine their thought process, communication skills, approach to oral exam question types, and decision-making ability.


Attendees must choose the Saturday OR Sunday Program when registering but not both. 

Please select which program day you wish to be in at the time of registration.  The selection is a first come basis and will be completed once you register. 

Note: All course registrants will receive their final and detailed schedules via a Tips Before You Click email scheduled to arrive on or before February 2, 2024.

AUA Guarantee: This course is backed by the AUA Guarantee: If you fail the boards, then we will pay for you to retake our course. (Applicable 2023 registrants please call 1-800-908-9414) 


AUA Members save 20%! For more information on membership benefits, visit www.AUAnet.org/Join

Registration Fees

Do not miss out on this valuable preparation with additional supporting sessions for your upcoming boards!

All for one low price—Register Now Before the Course is Sold Out!

 

Virtual Live Course 

Early Bird

On or Before December 29, 2023

Virtual Course Late

On or after

December 30, 2023

Oral Board Study Guide App*

AUA Member$1495$1865$150
AUA Non-Member$1865$2245

*Discounted Pricing on the Oral Board Study Guide App For Course Registrants Only (Regularly $299) 

Target Audience

  • Urologist

Learning Objectives

At the conclusion of this course, participants will be able to:

  1. Navigate the oral board exam format and question types successfully.
  2. Utilize interpersonal and communication skills resulting in effective information exchange.
  3. Demonstrate and refine skills to effectively manage anxiety and "exam nerves".
  4. Develop greater self-awareness and confidence in oral examination.
  5. Apply the experience gained in the AUA Oral Board Review Course to better prepare for the oral board exam.
  6. Practice and become familiar with the Objective Structured Clinical Examination (OSCE). 
Course summary
Course opens: 
07/29/2023
Course expires: 
02/11/2027
Event starts: 
02/10/2024 - 8:30am EST
Event ends: 
02/11/2024 - 7:00pm EST
List Price:
$2,245.00
Rating: 
0

Saturday Program                                                                                                           

Saturday, February 10, 2024, 8:30 AM – 7:00 PM EST*                                                    

*Please note that specific group assignments will be assigned and communicated via email 1-2 weeks prior to the course. Due to the complexities of the course structure, attendees may not make group requests or switch groups with any other attendee. The AUA will consider time zones to the best of our ability. Until otherwise notified, attendees should block off the entire timeframe listed above for course duration.

Includes:

  • Convenient, 1 Day Virtual Format!
  • 2 –75 minute Mock Exams with 1 Expert Examiner
  • Interactive Case Analysis with Expert Examiner
  • Objective Structured Clinical Examination (OSCE) Role Play Practice Session
  • Take Home Cases
  • Ask the Experts! Panel Discussion/Tips & Tricks with Faculty and ABU Process
  • Special Discount Pricing of the Oral Board Study Guide APP                                                                                                                          

Sunday Program

Sunday, February 11, 2024, 8:30 AM – 7:00 PM EST*                                                            

*Please note that specific group assignments will be assigned and communicated via email 1-2 weeks prior to the course. Due to the complexities of the course structure, attendees may not make group requests or switch groups with any other attendee. The AUA will consider time zones to the best of our ability. Until otherwise notified, attendees should block off the entire timeframe listed above for course duration.

Includes:

  • Convenient, 1 Day Virtual Format!
  • 2 –75 minute Mock Exams
  • Interactive Case Analysis with Expert Examiner
  • Objective Structured Clinical Examination (OSCE) Role Play Practice Session
  • Take Home Cases
  • Ask the Experts! Panel Discussion/Tips & Tricks with Faculty and ABU Process
  • Special Discount Pricing of the Oral Board Study Guide APP

Faculty Disclosures will be posted here prior to the course. 

Education Council Disclosures

PDF icon Education Council Disclosures.pdf

COI Review Work Group Disclosures

PDF icon COI Review Work Group Disclosures.pdf

Faculty Disclosures

Name

Company Name

Relationship Type

End Date

Babaian, Kara N.

Janssen

Scientific Study or Trial

10/19/2022

Badani, Ketan

Nothing relevant to disclose

 

 

Badlani, Gopal

Lithotripsy group : Piedmont stone & physcian disc

Other-Limited partner

Current

Badlani, Gopal

AAGUS

Leadership Position

Current

Badlani, Gopal

Neotract

Consultant or Advisor

Current

Badlani, Gopal

Urology times

Health Publishing

Current

Badlani, Gopal

Procept

Scientific Study or Trial

Current

Badlani, Gopal

Olympus

Scientific Study or Trial

Current

Badlani, Gopal

Boston Scientific

Scientific Study or Trial

Current

Baker, Karen C.

FrameFertility

Consultant or Advisor

Current

Baker, Karen C.

Diviner

Other-Forecaster

Current

Baker, Karen C.

Ysios Capital

Consultant or Advisor

Current

Bayne, Christopher

Journal of Pediatric Urology

Health Publishing

Current

Bayne, Christopher

Vidscrip

Consultant or Advisor

Current

Carroll, Peter Robert

NIH

Scientific Study or Trial

Current

Carroll, Peter Robert

Nutcracker Therapeutics

Consultant or Advisor

Current

Carroll, Peter Robert

Francis Medical

Consultant or Advisor

Current

Carroll, Peter Robert

Nutcracker Therapeutics

Consultant or Advisor

Current

Carroll, Peter Robert

Insigtec

Consultant or Advisor

10/23/2023

Carroll, Peter Robert

Biopharmcommunications

Health Publishing

09/06/2023

Carroll, Peter Robert

Francis Medical

Consultant or Advisor

10/23/2022

Carroll, Peter Robert

alessa

Consultant or Advisor

Current

Chi, Thomas

Boston Scientific Corporation

Consultant or Advisor

Current

Chi, Thomas

Auris

Consultant or Advisor

Current

Chi, Thomas

Bard Medical

Consultant or Advisor

Current

Chi, Thomas

Dornier

Consultant or Advisor

Current

Chi, Thomas

Cook

Consultant or Advisor

Current

Chi, Thomas

Lumenis

Consultant or Advisor

Current

Chi, Thomas

Applaud

Scientific Study or Trial

03/31/2023

Chi, Thomas

Vibronix

Consultant or Advisor

Current

Chi, Thomas

Mendaera

Consultant or Advisor

Current

Chi, Thomas

UroViu

Consultant or Advisor

Current

Chi, Thomas

Calyxo

Consultant or Advisor

Current

Clifton, Marisa M.

Nothing relevant to disclose

 

 

Comiter, Craig Vance

zenflow

Scientific Study or Trial

Current

Comiter, Craig Vance

Neuspera

Scientific Study or Trial

Current

Comiter, Craig Vance

BE technologies

Scientific Study or Trial

Current

Comiter, Craig Vance

coloplast

Scientific Study or Trial

Current

Comiter, Craig Vance

procept

Consultant or Advisor

Current

Dall'Era, Marc Arnaldo

MDxHealth

Scientific Study or Trial

04/26/2022

Dall'Era, Marc Arnaldo

Photocure

Consultant or Advisor

04/26/2022

Dall'Era, Marc Arnaldo

Janssen

Scientific Study or Trial

Current

Dall'Era, Marc Arnaldo

Tempus

Scientific Study or Trial

Current

Dall'Era, Marc Arnaldo

Prostatype Genomics

Consultant or Advisor

09/01/2023

Downs, Tracy M.

Nothing relevant to disclose

 

 

Droller, Michael J.

Miscellaneous legal expert consultant

Consultant or Advisor

Current

Droller, Michael J.

Elsevier Inc. (Urologic Oncology: Seminars and Ori

Leadership Position

Current

Eisner, Brian Howard

Boston Scientific

Consultant or Advisor

Current

Eisner, Brian Howard

Kalera Medical

Intellectual Property

Current

Eisner, Brian Howard

Sonomotion

Consultant or Advisor

Current

Eisner, Brian Howard

Allena Pharmaceuticals

Consultant or Advisor

Current

Eisner, Brian Howard

Dr. Arnies LLC

Intellectual Property

Current

Eisner, Brian Howard

Auris Robotics

Consultant or Advisor

Current

Eisner, Brian Howard

Olympus

Consultant or Advisor

Current

Eisner, Brian Howard

Cook Urological

Consultant or Advisor

Current

Eisner, Brian Howard

AMBU

Consultant or Advisor

Current

Giel, Dana W.

Nothing relevant to disclose

 

 

Gonzalgo, Mark

Clearcyte Diagnostics

Consultant or Advisor

Current

Gonzalgo, Mark

Organicell

Consultant or Advisor

Current

Gupta, Mantu

Cook Urological

Meeting Participant or Lecturer

Current

Gupta, Mantu

Olympus

Consultant or Advisor

Current

Gupta, Mantu

Boston Scientific Inc

Meeting Participant or Lecturer

Current

Gupta, Mantu

Retrophin Inc

Meeting Participant or Lecturer

06/01/2022

Gupta, Mantu

Applaud Medical

Scientific Study or Trial

02/20/2023

Hampson, Lindsay A.

Boston Scientific

Consultant or Advisor

08/15/2022

Ivancic, Vesna

Nothing relevant to disclose

Nothing relevant to disclose

Nothing relevant to disclose

Jacobs, Micah A.

Nothing relevant to disclose

Nothing relevant to disclose

Nothing relevant to disclose

Johnson, Brett A.

Ambu Inc

Scientific Study or Trial

01/01/2023

Johnson, Brett A.

Coloplast USA

Consultant or Advisor

10/01/2023

Kieran, Kathleen

Status: Nothing to disclose

 

 

Konety, Badrinath R.

Photocure

Consultant or Advisor

01/01/2023

Konety, Badrinath R.

Astrin Biosciences

Stock Option

Current

Konety, Badrinath R.

Styx Biotechnology

Stock Option

Current

Konety, Badrinath R.

Asieris Inc

Consultant or Advisor

Current

Konety, Badrinath R.

Ferrying Inc

Consultant or Advisor

04/01/2024

Konety, Badrinath R.

Illumina Inc

Consultant or Advisor

05/10/2024

Konety, Badrinath R.

Abbott Inc

Consultant or Advisor

Current

Konety, Badrinath R.

Bladder Cancer

Other-editorial board

Current

Konety, Badrinath R.

Translational Andrology Urology

Other-member editorial board

Current

Konety, Badrinath R.

American College of Surgeons

Other-member

Current

Konety, Badrinath R.

Society of Urologic Oncology

Other-member

Current

Konety, Badrinath R.

American Society of Clinical Oncology

Other-member

Current

Masterson, Timothy A.

SUO Fellowship Committee Chair & Institutional PD

Leadership Position

Current

Masterson, Timothy A.

Urologic Oncology journal

Health Publishing

Current

Mayer, Wesley A.

Applaud Medical

Scientific Study or Trial

Current

Mayer, Wesley A.

Novo Nordisk

Consultant or Advisor

Current

McAchran, Sarah Elizabeth

Pfizer

Investment Interest

Current

Mehta, Akanksha

Posterity Health

Other-Advisory Board Member

Current

Merrill, Suzanne B.

Photocure

Consultant or Advisor

Current

Munver, Ravi

Boston Scientific

Meeting Participant or Lecturer

12/31/2022

Munver, Ravi

Urogen, Inc

Meeting Participant or Lecturer

Current

Munver, Ravi

PROCEPT BioRobotics

Consultant or Advisor

Current

Munver, Ravi

Boston Scientific

Consultant or Advisor

Current

Ost, Michael C.

Nothing relevant to disclose

 

 

Peterson, Andrew Charles

BSCI: American Medical Systems INC

Consultant or Advisor

Current

Peterson, Andrew Charles

BSCI: Boston Scientific

Scientific Study or Trial

Current

Peterson, Andrew Charles

BSCI: Boston Scientific

Other-Course instructor

Current

Polascik, Thomas James

angiodynamics

Consultant or Advisor

07/17/2023

Polascik, Thomas James

Frances Medical

Consultant or Advisor

07/17/2023

Polascik, Thomas James

Galvanize

Consultant or Advisor

07/17/2023

Polascik, Thomas James

Merck

Scientific Study or Trial

07/17/2023

Polascik, Thomas James

Janssen

Scientific Study or Trial

07/17/2023

Polascik, Thomas James

Astellas

Scientific Study or Trial

07/17/2023

Polascik, Thomas James

Wasatch

Consultant or Advisor

07/17/2023

Porten, Sima Prabodh

Photocure

Scientific Study or Trial

Current

Porten, Sima Prabodh

Coloplast

Consultant or Advisor

10/31/2022

Porten, Sima Prabodh

Stryker

Consultant or Advisor

Current

Porten, Sima Prabodh

AstraZeneca

Consultant or Advisor

Current

Porten, Sima Prabodh

Pacific Edge

Consultant or Advisor

Current

Psutka, Sarah P.

Bladder Cancer Advocacy Network

Other-Research Grant Funding

Current

Psutka, Sarah P.

Janssen

Scientific Study or Trial

Current

Psutka, Sarah P.

European Urology

Leadership Position

Current

Psutka, Sarah P.

Bladder Cancer

Other-Editorial Board

Current

Psutka, Sarah P.

Medtronic

Other-Honoraria supporting travel to USANZ (AUA Lecture)

06/29/2022

Psutka, Sarah P.

ImmunityBio

Consultant or Advisor

Current

Ramasamy, Ranjith

Coloplast

Consultant or Advisor

Current

Ramasamy, Ranjith

Boston Scientific

Consultant or Advisor

Current

Ramasamy, Ranjith

Endo Pharmaceuticals

Consultant or Advisor

Current

Ramasamy, Ranjith

Acerus Pharmaceuticals

Scientific Study or Trial

01/17/2023

Rastinehad, Art R.

Philips, Inc

Scientific Study or Trial

Current

Rastinehad, Art R.

NanoSpectra Biopsciences

Consultant or Advisor

Current

Riley, Julie M.

Boston Scientific

Consultant or Advisor

Current

Schlomer, Bruce J.

Nothing relevant to disclose

 

 

Shridharani, Anand

Coloplast Inc

Consultant or Advisor

Current

Streeper, Necole M.

NIH

Scientific Study or Trial

Current

Terlecki, Ryan Patrick

Boston Scientific

Consultant or Advisor

Current

Terlecki, Ryan Patrick

U.S. Department of Defense

Scientific Study or Trial

Current

Woo, Lynn L.

Nothing relevant to disclose

 

 

AUA Office of Education Staff has nothing to disclose.

All relevant financial relationships have been mitigated.

AUA ACCREDITATION INFORMATION

ACCREDITATION: 

The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION: 

The American Urological Association designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER LEARNERS: 

The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

EVIDENCE BASED CONTENT: 

It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA DISCLOSURE POLICY: 

All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider all financial relationships with any commercial interest during the previous 24 months. The AUA must determine if the individual’s relationships may influence the educational content and mitigate any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

MITIGATION OF IDENTIFIED CONFLICT OF INTEREST: 

All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group Chair and/or Vice Chair for identification of conflicts of interest. The AUA COI Review Work Group, working with Office of Education staff, will document the mechanism(s) for management and mitigation of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to mitigate conflict of interest:

  • Peer review for valid, evidence-based content by the AUA COI Review Work Group.
  • Attestation that clinical recommendations are evidence-based and free of commercial bias.
  • Introduction of a debate format (point-counterpoint)
  • Inclusion of moderated panel discussion with unbiased moderator
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Divestiture of the relationship by faculty
  • Recusal from controlling relevant aspects of planning
  • Selection of alternative faculty for specific topic

OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES: 

The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

 
Status
Price
Title
$2,245.00Included
There are no more spaces available for this course.
$2,245.00Included
There are no more spaces available for this course.
$150.00Included
Please login or register to take this course.

Price

List Price:
$2,245.00
Please login or register to take this course.

Attendees must choose the Saturday OR Sunday Program when registering but not both. 

Please select which program day you wish to be in at the time of registration.  The selection is a first come basis and will be completed once you register. 

The Oral Board Study Guide App must be added to registration from this page for purchase.


AUA Members save 20%! For more information on membership benefits, visit www.AUAnet.org/Join

Registration Fees

Do not miss out on this valuable preparation with additional supporting sessions for your upcoming boards!

All for one low price—Register Now Before the Course is Sold Out!

 

Virtual Live Course 

Early Bird

On or Before December 29, 2023

Virtual Course Late

On or after

December 30, 2023

Oral Board Study Guide App*

AUA Member$1495$1865$150
AUA Non-Member$1865$2245

 


*Discounted Pricing on the Oral Board Study Guide App Only For Course Registrants (Regularly $299) 

 

Cancellation Policy

Live Virtual Course: An administrative fee of 15% is assessed if registration is cancelled up to six weeks prior to the course. If registration is cancelled four to six weeks from the course, the cancellation fee is 50% of the registration fee paid. No registration fees will be refunded less than four weeks prior to the course.

Registration Transfer: Customers switching from an option of lesser value to a higher value will be required to pay the difference in cost between the two options. Switching to an option of lesser value from a higher value must be made no later than six weeks prior to the course and will be subject to an administrative fee of 15% of the cost of the course from which they are transferring. Transfer of registration from a higher value option to an option of lesser value past six weeks prior to the course will not receive a refund.

Cancellations must be made in writing. Requests may be made via mail or fax to 410-689-3912. Questions? Call 1-800-908-9414 or email registration@AUAnet.org.

AUA Education & Research reserves the right to cancel this course if a minimum enrollment is not reached before December 29, 2023. If AUA Education & Research cancels this course, registration fees will be refunded in full and notification will be sent by January 12, 2024.


ATTENDEE INFORMATION & POLICIES

AUA Anti-Harassment Policy: AUA Commitment: AUA is committed to providing a safe and productive meeting environment that fosters open dialogue and the exchange of scientific ideas and is free of harassment and discrimination. All meeting participants are expected to behave professionally and treat others with respect, follow venue rules, and alert AUA staff or security of any dangerous situations or anyone in distress.

Reporting Harassment: It is the policy of the AUA that all meeting participants will enjoy an environment free from discrimination, harassment or retaliation. Harassing behavior by meeting participants will not be tolerated. If an individual experiences or witnesses harassment, he or she should contact Janet Skorepa, AUA EVP, at jskorepa@AUAnet.org or Maureen E. Cones, Esq., AUA General Counsel, at mcones@auanet.org or use a venue phone and ask for security if he or she feels unsafe. All complaints will be treated seriously and responded to promptly. 

The AUA reserves the right to take any action deemed necessary and appropriate, including refusing or revoking the registration of any individual, without refund, as long as such refusal is consistent with applicable law and AUA policy.

Disclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the American Urological Association (AUA).

Consent to Use of Photographic Images: Registration and attendance at or participation in AUA meetings and other activities constitutes an agreement by the registrant to AUA's use and distribution (both now and in the future) of the registrant or attendee's image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video, Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the AUA.

Special Assistance/Dietary Needs: The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, a written request should be submitted at least one month in advance. For additional assistance with your request please call 1-800-908-9414.